PhD
Professor, Division of Pharmacoengineering and Molecular Pharmaceutics
Clinical Assistant Professor, UNC Department of Neurosurgery
UNC-Chapel Hill
Molecular Therapeutics
Area of Interest
- Developing tumor-homing stem cell beacons for immune-based cancer therapy.
- Nanofiber matrices to improve neural stem cell mediated cancer therapy.
- Engineering stem cell therapies to understand and overcome glioblastoma adaption.
Awards and Honors
- Keystone Symposia Underrepresent, 2010
- American Brain Tumor Association, Post-doctoral Research Fellowship, 2008
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Minority Travel Award, American Physiological Society, 2005
- Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society, 2005
- College of Medicine Public Health Research Week Award, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, 2004
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Minority Travel Award, American Physiological Society, 2004
- Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society, 2004
- New Investigator Award, Society for Free Radical Biology and Medicine, 2003
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Minority Travel Award, American Physiological Society, 2003
- Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society, 2002
- College of Medicine Public Health Research Week Award, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, 2002
- Merck New Investigator Award, American Heart Association Council for High Blood Pressure Research, 2001
News and Stories
Devising a smarter way to treat brain tumors
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
Gel enhances CAR-T immunotherapy benefits in brains surgically treated for glioblastoma
Researchers from UNC Lineberger and colleagues report pairing a newly developed gel with immunotherapy that was delivered to post-surgical lab models with glioblastoma improved the immunotherapy’s effectiveness.
She ROCKS reaches $1 million milestone to support ovarian cancer research and care
She ROCKS supports the work of UNC Lineberger’s Victoria Bae-Jump, MD, and her work focusing on advancing the prevention, early detection and treatment of ovarian cancer.
Stem cells show promise as drug delivery tool for childhood brain cancer
UNC Lineberger’s Shawn Hingtgen, PhD, and his collaborators showed they could shrink tumors in laboratory models of medulloblastoma, and extend life. The study, published in PLOS ONE, is a necessary step toward developing clinical trials that would see if the approach works for children.
